Sponsor or institution

Clinical trials and research at Institute of Liver and Biliary Sciences, India

• 23Clinical trials
• 1Country

Newest trials

All recruiting trials (23)

• Developing and validating a formula to detect major kidney events in people with decompensated cirrhosis and ascites

  This observational study aims to test a new equation that helps identify major adverse kidney events in adults with decompensated cirrhosis and ascites who have stable kidney function.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT07794787

• Magnetic Resonance Cholangiopancreatography to help living liver donors and their recipients

  This study tests whether preoperative MRCP imaging can help select living liver donors and reduce biliary complications in recipients.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi · NCT07715500

• Genetic factors in graft fatty liver after living-donor liver transplant

  This study will see if donor and recipient genetic variants, especially PNPLA3 and MBOAT7, are linked to fat buildup in the transplanted liver among adults who had living-donor liver transplants for MAFLD-related cirrhosis.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi · NCT07685353

• Bone mineral changes after living-donor liver transplant

  Bone density scans will be used to see how bone mineral density changes in adults with chronic liver disease who receive a living-donor liver transplant.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT07480057

• How often staging laparoscopy finds hidden spread in liver, pancreas, and bile duct cancers

  This project will test whether staging laparoscopy still finds hidden metastases in people with suspected hepatopancreatobiliary cancers given modern imaging like CT, MRI, EUS, and PET-CT.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT07480005

• Oral Semaglutide for CKD and MAFLD in adults with diabetes

  This study tests whether adding oral semaglutide to standard care can slow kidney and liver disease progression in adults with CKD and MAFLD who have type 2 diabetes.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT07391267

• Whey versus egg white protein: which causes less ammonia rise in alcohol-related decompensated cirrhosis

  This trial will test whether 30 g of whey protein or 30 g of egg white protein causes a smaller rise in blood ammonia and affects minimal hepatic encephalopathy in adults with decompensated alcohol-related cirrhosis.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi · NCT07299110

• Understanding how chronic liver disease patients with organ failure fare after non‑emergency hospital stays

  This study follows adults with chronic liver disease who are admitted to the hospital non-electively to see how their condition develops over six months when liver and/or other organs fail.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT07270809

• How liver transplant affects sexual life and function

  This project will try to see if sexual function improves after liver transplant in married men with decompensated chronic liver disease and in men who already have a stable liver transplant.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT07268196

• How quickly blood albumin returns after major liver, pancreas, or bile-duct surgery predicts recovery

  This study will see if the speed at which serum albumin returns after major hepato‑pancreato‑biliary surgery predicts complications and hospital stay for patients aged 12 and up.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT07263061

• Pediatric autoimmune hepatitis: can a vegan diet reduce reliance on immunosuppressants

  In children with autoimmune hepatitis, this study tests whether adding a vegan diet for six months to standard treatment can help achieve liver disease remission compared with a standard high-protein diet.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT07118657

• Metformin plus carvedilol versus carvedilol alone to lower portal pressure in cirrhosis

  This trial tests whether adding metformin to carvedilol lowers portal pressure more than carvedilol alone in adults with cirrhosis who have had variceal bleeding.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT07108075

• Pentoxifylline to boost liver regrowth after right‑lobe donor hepatectomy

  This will try giving pentoxifylline to live liver donors having right‑lobe hepatectomy to see if the remaining liver grows faster and lowers the risk of post‑surgery liver problems.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi · NCT07085806

• Single vs repeated cycles of G-CSF and darbepoetin in early decompensated cirrhosis

  This trial tests whether giving multiple rounds of G-CSF plus darbepoetin helps people with early decompensated cirrhosis more than a single round or standard care.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT07002827

• Helicobacter infections and biliary tract cancers

  This study will test whether Helicobacter bacteria (H. pylori, H. bilis, H. hepaticus) are more common in people with biliary tract cancers than in people with benign gallbladder conditions or healthy liver donors.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT06909188

• Standard-volume versus high-volume plasma exchange for children with acute liver failure

  This trial will see if using high-volume plasma exchange instead of standard-volume plasma exchange helps children (ages 3–18) with acute liver failure keep their native liver.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT06831643

• Using different ROTEM cut-offs to guide blood transfusions before procedures in cirrhosis and ACLF

  This will test whether using relaxed ROTEM cut-offs to decide on blood transfusions reduces the number of transfusions without raising bleeding risk for people with cirrhosis or ACLF and severe coagulopathy who need invasive procedures.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT06831565

• Ceftazidime-avibactam vs high-dose meropenem for ACLF patients with hospital-acquired infections

  This trial tests whether ceftazidime-avibactam can better treat infections in ACLF patients than high-dose meropenem given in extended infusions, aiming to spare carbapenems if possible.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT06818565

• Indian-style Mediterranean diet versus low-fat diet to reduce liver fat in overweight children with MASLD

  This project will try to see if an Indianized Mediterranean diet or a low-fat diet better reduces liver fat in overweight children and teens with MASLD over 180 days.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT06768216

• Using rifaximin to improve liver transplant outcomes

  This study is testing if taking the antibiotic rifaximin before and after liver transplant surgery can help prevent early problems with the new liver in adults.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT06743464

• Establishing a registry for Glycogen Storage Diseases in Indian children

  This study is trying to create a detailed registry of children in India with Glycogen Storage Diseases to better understand their symptoms and health outcomes.

  Recruiting at 37 sites Institute of Liver and Biliary Sciences, India · Guindy, Chennai and 36 other locations · NCT06396546

• Using Tenofovir Alafenamide to Prevent Liver Disease Progression in Chronic Hepatitis B

  This study is testing if a medication called Tenofovir Alafenamide can help people with chronic Hepatitis B who have normal liver function and low virus levels avoid worsening liver disease.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT05195450

• Carvedilol to prevent esophageal varices in people with cirrhosis

  This will try whether taking carvedilol twice daily for one year can prevent esophageal varices in adults (18–75) with cirrhosis who do not currently have varices, compared with a placebo.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT01212250

Quick answers

How many clinical trials run by Institute of Liver and Biliary Sciences, India are recruiting right now?

23, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in India. Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →